S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CPRX Catalyst Pharmaceuticals Inc

22.32

0.00 (0.00%)

Pre Market

Last Updated: 05:53:43

Delayed by 15 minutes

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]

Catalyst Pharmaceuticals (NASDAQ:CPRX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Catalyst Pharmaceuticals Charts.

Catalyst Pharmaceuticals (NASDAQ:CPRX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Catalyst Pharmaceuticals Charts.

Catalyst Pharmaceuticals Inc News

Form 144 - Report of proposed sale of securities
Monday 3 March 2025 (15 hours ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Monday 3 March 2025 (21 hours ago) • Edgar (US Regulatory)

Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
Friday 28 February 2025 (4 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 26 February 2025 (6 days ago) • Edgar (US Regulatory)

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Wednesday 26 February 2025 (6 days ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Wednesday 26 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 19 February 2025 (2 weeks ago) • Edgar (US Regulatory)

More Catalyst Pharmaceuticals Inc News Articles

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions